Company Description
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally.
It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.
The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services.
It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting.
In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment.
It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals.
The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015.
STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
| Country | United States |
| Founded | 1985 |
| IPO Date | Jun 1, 1992 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 17,937 |
| CEO | Daniel Carestio |
Contact Details
Address: 5960 Heisley Road Mentor, Ohio 44060 United States | |
| Phone | 440 354 2600 |
| Website | steris.com |
Stock Details
| Ticker Symbol | STE |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001757898 |
| CUSIP Number | G8473T100 |
| ISIN Number | IE00BFY8C754 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Daniel A. Carestio | President, Chief Executive Officer and Director |
| John Adam Zangerle | Senior Vice President, General Counsel and Secretary |
| Mary Clare Fraser | SVice President and Chief Human Resources Officer |
| Cary L. Majors | Senior Vice President and President of Healthcare |
| Karen L. Burton | Senior Vice President, Chief Financial Officer and Chief Accounting Officer |
| Julie Winter | Vice President of Investor Relations and Corporate Communications |
| Lindsey McGowan | Vice President, Chief Compliance and Quality Officer |
| Julia K. Madsen | Senior Vice President and GM of Life Sciences |
| Andrew Xilas | Senior Vice President and GM of Dental |
| Kenneth E. Kohler | Senior Vice President and GM of AST |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 5, 2026 | 144 | Filing |
| Jun 4, 2026 | 144 | Filing |
| Jun 2, 2026 | 144 | Filing |
| Jun 1, 2026 | SD | Form - SD |
| May 29, 2026 | 10-K | Annual Report |
| May 12, 2026 | SCHEDULE 13G | Filing |
| May 11, 2026 | 8-K | Current Report |
| May 7, 2026 | 8-K | Current Report |
| Apr 30, 2026 | SCHEDULE 13G | Filing |
| Apr 29, 2026 | SCHEDULE 13G | Filing |